SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001520138-15-000410
Filing Date
2015-10-01
Accepted
2015-09-30 18:13:57
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDED JUNE 30, 2015 nnab-20150630_10k.htm 10-K 445623
2 EXHIBIT 31.1 nnab-20150630_10kex31z1.htm EX-31.1 12496
3 EXHIBIT 32.1 nnab-20150630_10kex32z1.htm EX-32.1 6202
4 GRAPHIC image_001.jpg GRAPHIC 19010
5 GRAPHIC image_002.jpg GRAPHIC 3576
  Complete submission text file 0001520138-15-000410.txt   1296563

Data Files

Seq Description Document Type Size
6 XBRL DEFINITION FILE nnab-20150630_def.xml EX-101.DEF 18034
7 XBRL LABEL FILE nnab-20150630_lab.xml EX-101.LAB 95674
8 XBRL PRESENTATION FILE nnab-20150630_pre.xml EX-101.PRE 72688
9 XBRL SCHEMA FILE nnab-20150630.xsd EX-101.SCH 12759
10 XBRL INSTANCE FILE nnab-20150630.xml EX-101.INS 108331
11 XBRL CALCULATION FILE nnab-20150630_cal.xml EX-101.CAL 15918
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55292 | Film No.: 151134837
SIC: 2834 Pharmaceutical Preparations